The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTaylor Wimpey Regulatory News (TW.)

Share Price Information for Taylor Wimpey (TW.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 134.30
Bid: 134.50
Ask: 134.60
Change: 2.85 (2.17%)
Spread: 0.10 (0.074%)
Open: 132.30
High: 135.10
Low: 132.15
Prev. Close: 131.45
TW. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board and Committee changes

24 Feb 2020 16:26

RNS Number : 9552D
Taylor Wimpey PLC
24 February 2020
 

 

Taylor Wimpey plc - Board and Board Committee Changes: Independent Non Executive Directors

The Board of Taylor Wimpey plc announces the following changes in the composition of its Board and Board Committees:

Having served as a Non Executive Director since April 2011, Dame Kate Barker will stand down from the Board on 31 July 2020. Kate has kindly agreed to extend marginally beyond her nine year point at the Board's request to provide a short period of continuity to new Chair Irene Dorner who, as previously announced, will assume the Chair on 26 February 2020.

Kate will stand down as a member of the Audit and Remuneration Committees and relinquish her current role as the Company's Senior Independent Director at her nine year point on 20 April 2020, before formally retiring from the Board on 31 July 2020.

The Company is pleased to announce that Kate will be succeeded as the Company's Senior Independent Director by Robert Noel. Rob joined the Board as an independent Non Executive Director on 1 October 2019.

Kevin Beeston, Chair, said:

"I would like to express both my own and the Board's immense gratitude to Kate for her long and valued contribution to the Company over the past nine years, during which she has provided wise counsel as Senior Independent Director to myself as Chair; careful oversight of the Board Committees on which she has served during that time, particularly as Chair of the Remuneration Committee for over two years; and made an invaluable contribution to the Board's deliberations and the Company's progress. She has been a great colleague and a great contributor throughout her tenure as a Director. We are also grateful to Kate for her willingness to remain as a member of the Board until July and we wish her all the very best for the future."

 

-ends-

 

24 February 2020

 

For further information please contact:

 

Taylor Wimpey plc Tel: +44 (0) 1494 885616 

 

Alice Marsden, Group General Counsel and Company Secretary

Debbie Archibald, Investor Relations

 

Finsbury Tel: +44 (0) 20 7251 3801

Faeth Birch

Anjali Unnikrishnan

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAFLFFRFVISFII
Date   Source Headline
23rd Apr 20241:29 pmRNSResult of AGM
23rd Apr 20247:00 amRNSTrading Statement
16th Apr 20245:10 pmRNSDirector/PDMR Shareholding
9th Apr 20244:34 pmRNSDirector/PDMR Shareholding
2nd Apr 202411:22 amRNSTotal Voting Rights
28th Mar 202410:09 amRNSDirector/PDMR Shareholding
20th Mar 20243:17 pmRNSAnnual Financial Report and Notice of AGM
11th Mar 20243:17 pmRNSDirector/PDMR Shareholding
7th Mar 20242:05 pmRNSDirector/PDMR Shareholding
1st Mar 20249:09 amRNSTotal Voting Rights
29th Feb 20244:15 pmRNSDirector/PDMR Shareholding
28th Feb 20247:00 amRNSTAYLOR WIMPEY PLC FULL YEAR RESULTS
9th Feb 202412:52 pmRNSDirector/PDMR Shareholding
1st Feb 202410:41 amRNSTotal Voting Rights
11th Jan 20247:00 amRNSTrading Statement
9th Jan 20244:28 pmRNSDirector/PDMR Shareholding
8th Jan 20244:19 pmRNSBlock listing Interim Review
8th Jan 20244:16 pmRNSBlock listing Interim Review
4th Jan 20244:54 pmRNSTotal Voting Rights - Replacement
2nd Jan 202411:04 amRNSTotal Voting Rights
21st Dec 20233:15 pmRNSHolding(s) in Company
20th Dec 20237:00 amRNSHolding(s) in Company
13th Dec 20234:39 pmRNSDirector/PDMR Shareholding
11th Dec 20234:52 pmRNSDirector/PDMR Shareholding
1st Dec 20233:49 pmRNSTotal Voting Rights
30th Nov 20234:26 pmRNSDirector/PDMR Shareholding
28th Nov 20234:01 pmRNSDirector/PDMR Shareholding
27th Nov 20234:05 pmRNSHolding(s) in Company
9th Nov 202311:59 amRNSDirector/PDMR Shareholding
9th Nov 20237:00 amRNSTrading Statement
1st Nov 202311:17 amRNSTotal Voting Rights
10th Oct 20232:26 pmRNSDirector/PDMR Shareholding
2nd Oct 20232:13 pmRNSTotal Voting Rights
13th Sep 20234:31 pmRNSHolding(s) in Company
11th Sep 20232:19 pmRNSDirector/PDMR Shareholding
1st Sep 20233:32 pmRNSHolding(s) in Company
1st Sep 20239:26 amRNSTotal Voting Rights
29th Aug 20237:01 amRNSHolding(s) in Company
29th Aug 20237:00 amRNSHolding(s) in Company
9th Aug 20232:31 pmRNSDirector/PDMR Shareholding
2nd Aug 20237:00 amRNSHalf year results 2023
1st Aug 20232:44 pmRNSTotal Voting Rights
21st Jul 20234:08 pmRNSHolding(s) in Company
11th Jul 20233:19 pmRNSDirector/PDMR Shareholding
3rd Jul 202312:07 pmRNSTotal Voting Rights
27th Jun 20237:00 amRNSZero carbon ready homes trial visit
14th Jun 20234:20 pmRNSHolding(s) in Company
9th Jun 20232:26 pmRNSDirector/PDMR Shareholding
1st Jun 20232:50 pmRNSTotal Voting Rights
23rd May 20234:05 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.